GlaxoSmithKline
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Established
- 1929-01-01
- Employees
- 70.2K
- Market Cap
- $90B
- Website
- http://www.gsk.com
- Introduction
GSK Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and consumer healthcare products. It operates through the Commercial Operations, and Research and Development segments. The Commercial Operations segment has three product groups of specialty medicines, vaccines, and general medicines. The company was founded in 1715 and is headquartered in Middlesex, the United Kingdom.
Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients
- Conditions
- Overactive BladderIncontinence, Urinary and Urinary Bladder, Overactive
- First Posted Date
- 2006-06-01
- Last Posted Date
- 2015-04-17
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 1
- Registration Number
- NCT00332319
- Locations
- 🇺🇸
GSK Investigational Site, Philadelphia, Pennsylvania, United States
Effects Of Prednisolone On Rheumatoid Arthritis Patients
- Conditions
- Arthritis, Rheumatoid
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2012-10-22
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 32
- Registration Number
- NCT00330889
- Locations
- 🇬🇧
GSK Investigational Site, Sheffield, United Kingdom
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
- Conditions
- Parkinson Disease
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2017-08-22
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 343
- Registration Number
- NCT00331149
- Locations
- 🇬🇧
GSK Investigational Site, Oxford, United Kingdom
Study Of Bupropion SR (323U66) In Patients With Major Depressive Disorder In Japan
- Conditions
- Major Depressive Disorder (MDD)
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2015-05-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 35
- Registration Number
- NCT00330616
- Locations
- 🇯🇵
GSK Investigational Site, Tokyo, Japan
Comparison Of Molecular Targets In Mild To Severe Asthmatics And Healthy Subjects
- Conditions
- Asthma
- Interventions
- Procedure: BronchoscopsyProcedure: Prednisolone
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2017-06-28
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 58
- Registration Number
- NCT00331058
- Locations
- 🇺🇸
GSK Investigational Site, Philadelphia, Pennsylvania, United States
A Methodology Study To Look At Genes In Lung Cells And Tissue From Asthmatic Patients
- Conditions
- Asthma
- First Posted Date
- 2006-05-29
- Last Posted Date
- 2008-10-16
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 30
- Registration Number
- NCT00331292
- Locations
- 🇺🇸
GSK Investigational Site, Philadelphia, Pennsylvania, United States
Long-term Study Of Ropinirole In Restless Legs Syndrome
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2017-03-23
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 404
- Registration Number
- NCT00329602
- Locations
- 🇨🇭
GSK Investigational Site, Zürich, Switzerland
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
- Conditions
- Infections, Rotavirus
- Interventions
- Biological: Rotarix™Biological: Placebo
- First Posted Date
- 2006-05-25
- Last Posted Date
- 2016-12-09
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 8687
- Registration Number
- NCT00329745
- Locations
- 🇸🇬
GSK Investigational Site, Singapore, Singapore
ARIXTRA Local Study For Registration In China.
- Conditions
- ThromboembolismKnee ReplacementHip Replacement
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2012-06-04
- Lead Sponsor
- GlaxoSmithKline
- Target Recruit Count
- 240
- Registration Number
- NCT00328939
- Locations
- 🇨🇳
GSK Investigational Site, Shanghai, China
Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea
- Conditions
- Diabetes Mellitus, Type 2Essential Hypertension
- Interventions
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2010-08-16
- Lead Sponsor
- GlaxoSmithKline
- Registration Number
- NCT00328965